PERLETTI, GIANPAOLO
 Distribuzione geografica
Continente #
NA - Nord America 14.373
EU - Europa 8.622
AS - Asia 6.275
SA - Sud America 844
AF - Africa 332
OC - Oceania 163
Continente sconosciuto - Info sul continente non disponibili 14
Totale 30.623
Nazione #
US - Stati Uniti d'America 14.093
IT - Italia 4.201
SG - Singapore 1.796
UA - Ucraina 1.251
CN - Cina 1.154
VN - Vietnam 798
TR - Turchia 684
BR - Brasile 670
SE - Svezia 663
HK - Hong Kong 634
GB - Regno Unito 460
IE - Irlanda 388
DE - Germania 354
FI - Finlandia 346
FR - Francia 309
IN - India 269
RU - Federazione Russa 209
CA - Canada 163
AU - Australia 133
IQ - Iraq 108
ID - Indonesia 103
PK - Pakistan 97
NG - Nigeria 95
IR - Iran 94
MX - Messico 86
JP - Giappone 71
KR - Corea 65
ES - Italia 64
EG - Egitto 59
BD - Bangladesh 58
PL - Polonia 57
AR - Argentina 55
NL - Olanda 51
ZA - Sudafrica 51
TW - Taiwan 49
BE - Belgio 48
TH - Thailandia 48
MY - Malesia 41
PH - Filippine 40
GR - Grecia 38
NZ - Nuova Zelanda 27
EC - Ecuador 26
NP - Nepal 25
PE - Perù 23
CZ - Repubblica Ceca 22
DZ - Algeria 22
JO - Giordania 22
AT - Austria 21
CO - Colombia 20
UG - Uganda 20
BG - Bulgaria 19
GH - Ghana 19
RS - Serbia 19
KE - Kenya 17
PT - Portogallo 17
MA - Marocco 16
SA - Arabia Saudita 16
UZ - Uzbekistan 16
IL - Israele 15
VE - Venezuela 15
CH - Svizzera 13
CL - Cile 13
EU - Europa 13
RO - Romania 12
LT - Lituania 10
QA - Qatar 10
YE - Yemen 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
TN - Tunisia 9
HU - Ungheria 8
SK - Slovacchia (Repubblica Slovacca) 8
UY - Uruguay 8
DK - Danimarca 7
ET - Etiopia 7
BO - Bolivia 6
PY - Paraguay 6
SN - Senegal 6
AZ - Azerbaigian 5
CU - Cuba 5
LB - Libano 5
PS - Palestinian Territory 5
CR - Costa Rica 4
GT - Guatemala 4
HN - Honduras 4
LK - Sri Lanka 4
BH - Bahrain 3
FJ - Figi 3
KW - Kuwait 3
LU - Lussemburgo 3
MD - Moldavia 3
MM - Myanmar 3
NI - Nicaragua 3
OM - Oman 3
SD - Sudan 3
SI - Slovenia 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AF - Afghanistan, Repubblica islamica di 2
BF - Burkina Faso 2
Totale 30.590
Città #
Milan 2.827
Fairfield 1.592
Ashburn 1.189
Singapore 1.042
Woodbridge 1.031
Jacksonville 953
San Jose 889
Chandler 821
Houston 796
Seattle 681
Wilmington 616
Hong Kong 586
Cambridge 566
Ann Arbor 493
Dublin 374
Princeton 368
Dearborn 343
Nyköping 337
Dallas 303
Izmir 300
Beijing 268
Rome 251
The Dalles 227
Boardman 225
Chicago 211
Dong Ket 195
Lauterbourg 181
Como 167
Ho Chi Minh City 167
Los Angeles 122
San Mateo 122
San Diego 116
New York 112
Hanoi 105
Council Bluffs 78
Ogden 76
Santa Clara 76
London 73
Orem 58
Tokyo 55
Guangzhou 54
Helsinki 54
São Paulo 53
Abuja 49
Montreal 43
Shanghai 43
Jakarta 39
Munich 39
Chennai 37
Warsaw 37
Bangkok 36
Brisbane 36
Sydney 36
Nanjing 35
Verona 35
Hefei 34
Kocaeli 33
Toronto 33
Mexico City 32
Brooklyn 31
Kunming 31
Manchester 31
Washington 30
Sulaymaniyah 29
San Francisco 28
Cairo 26
Atlanta 25
Lahore 25
Phoenix 25
Baghdad 24
Pioltello 24
Rio de Janeiro 24
Denver 23
Moscow 23
Mumbai 23
Johannesburg 22
Shenzhen 22
Amman 21
Lagos 21
Portland 21
Rozzano 21
Tianjin 21
Brussels 20
Nuremberg 20
Stockholm 20
Boston 19
Frankfurt am Main 19
Pune 19
Kampala 18
Ankara 17
Athens 17
Brno 17
Haiphong 17
Hangzhou 17
Manila 17
Melbourne 17
Norwalk 17
Taipei 17
Adelaide 16
Kuala Lumpur 16
Totale 20.641
Nome #
Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer 923
Infectious complications of endourological treatment of kidney stones: A meta-analysis of randomized clinical trials 672
Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials 656
Serenoa repens and its effects on male sexual function. A systematic review and meta-analysis of clinical trials 391
Effect of alpha-adrenoceptor antagonists on sexual function. A systematic review and meta-analysis 282
Prostatic calcifications are associated with a more severe symptom burden in men with type II chronic bacterial prostatitis 266
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid. 256
The Integral Theory System Questionnaire: an anatomically directed questionnaire to determine pelvic floor dysfunctions in women 246
Risk of urinary stone formation associated to proton pump inhibitors: a systematic review and metanalysis 232
Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assay 232
Serenoa repens and Pygeum Africanum in the treatment of BPH 232
Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up 230
ANALYSIS OF CALCIUM-DEPENDENT PROTEIN-KINASE-C ISOFORMS IN THE EARLY STAGES OF DIETHYLNITROSAMINE-INDUCED RAT HEPATOCARCINOGENESIS 229
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex 223
Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination. 222
Discrepancies between in silico and in vitro data in the functional analysis of a breast cancer-associated polymorphism in the XRCC6/Ku70 gene. 219
Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity 218
Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients 215
National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome. 211
Are oxygen radicals responsible for the acute cardiotoxicity of doxorubicin? 210
Effect of HIF-1 modulation on the response of two- and three-dimensional cultures of human colon cancer cells to 5-fluorouracil 207
Anti-infective treatment of bacterial urinary tract infections. 205
Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity. 205
Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg). 205
Chronic bacterial prostatitis: enterococcal disease? 205
A new approach to the direct detection of free radicals in the intact myocardium. 204
Increased chromosomal radiosensitivity in asymptomatic carriers of a heterozygous BRCA1 mutation 200
Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction. 199
Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis 198
Natural history of human papillomavirus infection in non-vaccinated young males: low clearance probability in high-risk genotypes 198
Activity of Serenoa repens, lycopene and selenium on prostatic disease: evidences and hypotheses. 197
Computer-assisted quantitative assessment of prostatic calcifications in patients with chronic prostatitis 197
Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials 196
Antimicrobials in urogenital infections. 196
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes 195
A severely symptomatic case of anaerobic chronic bacterial prostatitis successfully resolved with moxifloxacin therapy. 194
Azithromycin: mechanisms of action and their relevance for clinical applications. 191
Finafloxacin for the treatment of urinary tract infections 191
Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations. 191
α-blockers and antibiotics, alone or in combination, improve symptoms in men with chronic prostatitis/chronic pelvic pain syndrome. 189
p21(Waf1/Cip1) and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells 188
Antimicrobial therapy for chronic bacterial prostatitis. 188
Prevalence of erectile and ejaculatory dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome 186
National institute of health chronic prostatitis symptom index (CPSI) symptom evaluation in patients with chronic prostatitis / chronic pelvic pain syndrome - A multinational study in 1,563 patients 185
FRAIL scale as a predictor of complications and mortality in older patients undergoing reconstructive surgery for non-melanoma skin cancer 185
Semen analysis in chronic bacterial prostatitis: diagnostic and therapeutic implications. 184
Macrolides for the treatment of chronic bacterial prostatitis: an effective application of their unique pharmacokinetic and pharmacodynamic profile (Review). 183
A polymorphism in the promoter region of Ku70/XRCC6, associated with breast cancer risk and oestrogen exposure. 182
A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study. 182
Efficacy of repeated cycles of combination therapy for the eradication of infecting organisms in chronic bacterial prostatitis 180
Inflammatory cues acting on the adult intestinal stem cells and the early onset of cancer (Review) 179
INTERACTION OF CU(II) AND CU(II)-ANTHRACYCLINE COMPLEXES WITH PROTEIN-KINASE-C - SPECTROMAGNETIC ASSESSMENT OF THE INHIBITORY EFFECT 179
Structure and function of the extraembryonic membrane persisting around the larvae of the parasitoid Toxoneuron nigriceps. 178
Emerging second-line therapies for advanced, androgen deprivation-refractory prostate cancer in the post-docetaxel setting 177
Prevention and modulation of aminoglycoside ototoxicity (Review) 173
Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer 173
Leech responses to tissue transplantation 172
Polymorphisms in nonhomologous end joining genes associated with breast cancer risk and chromosomal radiosensitivity. 171
Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate 171
Collagen organization in leech wound healing. 170
DIFFERENTIAL PHORBOL ESTER GROWTH MODULATION AND PROTEIN-KINASE-C ISOENZYME EXPRESSION IN RAT HEPATOMA-CELLS VS NON NEOPLASTIC RAT HEPATOCYTES 170
PROTECTIVE EFFECTS OF SPIN-TRAPPING AGENTS ON ADRIAMYCIN-INDUCED CARDIOTOXICITY IN ISOLATED RAT ATRIA 170
Chlamydia trachomatis infection is related to premature ejaculation in chronic prostatitis patients: Results from a cross-sectional study 169
Resistance of human leukemic cell lines to 1-beta-D-arabinofuranosylcytosine: characterization of an experimental model 166
Phosphatidylethanolamine N-methyltransferase 2 and CTP-phosphocholine cytidylyltransferase expressions are related with protein kinase C isozymes in developmental liver growth 166
Emerging drugs for bacterial urinary tract infections. 166
A switch therapy protocol with intravenous azithromycin and ciprofloxacin combination for severe, relapsing chronic bacterial prostatitis: a prospective non-comparative pilot study. 165
Growth factors and chemokines: a comparative functional approach between invertebrates and vertebrates. 164
PROTEIN-KINASE-C ISOZYME PATTERN IN LIVER HYPERPLASIA 161
PROTEIN-KINASE-C ISOZYMES DURING LIVER-REGENERATION 161
THE INHIBITORY EFFECT OF CU(II) ON PROTEIN-KINASE-C IS ENHANCED BY ANTHRACYCLINES - AN ESR STUDY 161
Hypoxia as a risk factor for doxorubicin-induced cardiotoxicity: a NMR evaluation. 161
Topographic and quantitative relationship between prostate inflammation, proliferative inflammatory atrophy and low-grade prostate intraepithelial neoplasia: A biopsy study in chronic prostatitis patients 160
Risk factors analysis in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) from Finland, Germany, Italy and Switzerland: Results of a multinational observational study 160
Early suppression of immune response in Heliothis virescens larvae by the endophagous parasitoid Toxoneuron nigriceps 160
Effect of trimetazidine on early and delayed doxorubicin myocardial toxicity. 159
Re: Samplaski et al.: Inclusion of erectile domain to UPOINT phenotype does not improve correlation with symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome. (Urology 2011;78:653-658). 159
Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome 158
Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection. 157
PARTIAL-PURIFICATION OF PROTEIN-KINASE-C ISOENZYMES FROM RAT-LIVER 157
VEGF stimulates angiogenesis in Hirudo medicinalis. 156
ANALYSIS OF CALCIUM-DEPENDENT PROTEIN-KINASE-C ISOENZYMES IN INTRINSICALLY RESISTANT CLONED LINES OF LOVO CELLS - REVERSAL OF RESISTANCE BY KINASE INHIBITOR 1-(5-ISOQINOLINYLSULFONYL) 2-METHYLPIPERAZINE 155
Effect of doxorubicin on calcium receptors of myocardial cells. 155
Resistance of uropathogens to antibacterial agents: Emerging threats, trends and treatments 155
Wound repair in Hirudo medicinalis: phases and response modulation 153
THE ACTIVITY OF A BETA-SUBTYPE OF PROTEIN-KINASE-C PURIFIED FROM NUCLEI OF HUMAN NEUTROPHILS IS ENHANCED BY TREATMENT WITH PHORBOL 12-MYRISTATE 13-ACETATE 153
Distinctive cellular roles for novel protein kinase C isoenzymes 153
Comparative analysis of immune responses and cytokine profiles elicited in rabbits by the combined use of recombinant fowlpox viruses, plasmids and virus-like particles in prime-boost vaccination protocols against SHIV 152
Chlamydia trachomatis versus common uropathogens as a cause of chronic bacterial prostatitis: Is there any difference? Results of a prospective parallel-cohort study 152
Multidisciplinary approach to prostatitis 152
The radiosensitizing effect of Ku70/80 knockdown in MCF10A cells irradiated with X-rays and p(66)+Be(40) neutrons. 151
Leeches: Immune response, angiogenesis and biomedical applications 150
The association between prostatitis and prostate cancer. Systematic review and meta-analysis 150
Levofloxacin for NIH Category II Chronic Bacterial Prostatitis: A Real-Life Study 150
Hematopoietic cell formation in leech wound healing. 150
Hirudo medicinalis: a new model system for testing activators and inhibitors of angiogenesis 149
Antimicrobials in urogenital infections. 148
Herbal medicines for urinary stone treatment. A systematic review 146
Chronic prostatic infection: Microbiological findings in two Mediterranean populations 145
Collagen reorganization in leech wound healing. 144
Totale 20.183
Categoria #
all - tutte 114.055
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.055


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021952 0 0 0 0 0 0 0 0 0 223 268 461
2021/20221.970 190 191 128 173 31 99 82 152 258 240 154 272
2022/20232.265 262 122 235 199 170 488 3 284 285 79 75 63
2023/20244.839 675 731 765 812 905 256 60 109 148 118 117 143
2024/20254.058 136 145 605 134 184 221 176 303 417 422 404 911
2025/20267.200 608 494 440 1.054 749 468 1.580 558 829 420 0 0
Totale 30.852